filmov
tv
Mizuho Americas discusses outlook for China markets and investor confidence
Показать описание
Farzin Azarm, managing director of equities trading at Mizuho Americas, discusses the outlook for Chinese markets and state intervention.
CNBC International Live
CNBC
Рекомендации по теме
0:03:22
Mizuho Americas discusses outlook for China markets and investor confidence
0:08:03
Equity Capital Markets: 2024 Post-Election Outlook
0:05:19
Healthcare has 'been so bad, maybe it's gonna be good' in 2025, says Mizuho's Ja...
0:08:10
Economy's structure suggests inflation bottoming out above Fed's target: Economist
0:05:04
Mizuho: A company like Broadcom can't miss the top-line even if you raise AI guidance
0:07:56
The U.S. economy will ‘roll over very, very quickly’ in 2022: Economist
0:05:24
Top Calls: Uber Delivers Mixed 3Q Report, Outlook
0:04:29
The market is off base here,’ not the Fed: Economist
0:04:27
Mizuho: Real estate concerns are priced in, and REITS offer a good defense
0:03:20
Here's how 3M's growing legal battle is impacting its stock
0:05:32
#TradeTalks: #2020Outlook Energy Markets
0:07:14
GDP Forecasts May Be Too High, Mizuho's Ricchiuto Says
0:09:54
Analyst discusses oil going to negative $100 per barrel and other possible scenarios
0:06:19
As long as Israel-Hamas war doesn't expand, oil prices could slide a bit: Expert
0:45:10
The Open Full Show
0:05:12
Affirm could be the Visa or Mastercard of buy now, pay later, says Mizuho's Dan Dolev
0:05:19
Energy Outlook Global Demand Continues to Slow
0:03:06
Pfizer's Covid vaccine approval adds certainty to the stock: Mizuho analyst
0:07:25
Home Depot and Lowe's are preparing for a 'renovation boom,' analyst says
0:53:51
Mizuho Speaker Series: CEO is Out and All-In for Equality
1:33:39
Rio Tinto, Glencore Said to Discuss Mega Mining Deal | Bloomberg: The Asia Trade 1/17/25
0:07:14
The analyst: Vikram Malhotra on return-to-work and office REITs
0:05:10
Musk's managing five companies — who wouldn't be overstretched, says fmr. Tesla board memb...
0:07:45
Investing in Oncology-Focused Companies